All In MedTech

Device Trial Radar · NCT06335966

BEST-RPP Pilot: Screening for Esophageal Cancer in Rural Oregon Without an Endoscopy

Barrett's Esophagus Screening Towards Rural Referral Pathways: Screening for Esophageal Cancer in Rural Oregon Without Endoscopy

Last checked: Nov 19, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

48

Actual

Start

Sep 11, 2024

Primary completion

Dec 30, 2024

Study completion Oct 6, 2026

Sponsor

Lead sponsor
OHSU Knight Cancer InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Kuni Foundation; Oregon Health and Science University
First posted
Mar 28, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
Male only, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Recent advancements in swallowable esophageal cell-collection devices (SECD) offer a safe, minimally invasive, accurate, and low-cost alternative to esophageal screening without the need for an upper endoscopy. The BEST-RPP study aims to evaluate the acceptability and feasibility of using this novel approach to screen for Barrett's Esophagus (BE) and Esophageal Carcinoma (EAC) in rural primary care clinic settings in Oregon.

Conditions

  • Esophageal Cancer

Interventions

  • Screening with swallowable esophageal cell-collection devices (SECD)Device

    All participants who enroll in this study and provide their consent will undergo screening with an FDA approved swallowable esophageal cell-collection device (SECD)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Feasibility of the use of a SECD: Number of providers who indicate likelihood of using SECDTime frame: 8 months
  2. Feasibility of the use of SECD: Number of providers who indicate willingness to be trained and train clinic staffTime frame: 8 months
  3. Feasibility of the use of SECD: Number of referralsTime frame: 8 months

4 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • OHSU Knight Cancer Institute

    Portland, Oregon

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.